Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Invested Capital (2020 - 2025)

Historic Invested Capital for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $3.1 million.

  • iSpecimen's Invested Capital fell 3482.52% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 3482.52%. This contributed to the annual value of $3.3 million for FY2024, which is 6600.98% down from last year.
  • iSpecimen's Invested Capital amounted to $3.1 million in Q3 2025, which was down 3482.52% from $621973.0 recorded in Q2 2025.
  • iSpecimen's 5-year Invested Capital high stood at $29.8 million for Q4 2021, and its period low was $621973.0 during Q2 2025.
  • Over the past 5 years, iSpecimen's median Invested Capital value was $12.4 million (recorded in 2021), while the average stood at $12.9 million.
  • As far as peak fluctuations go, iSpecimen's Invested Capital surged by 23130.56% in 2021, and later plummeted by 8978.58% in 2025.
  • iSpecimen's Invested Capital (Quarter) stood at $29.8 million in 2021, then plummeted by 31.83% to $20.3 million in 2022, then tumbled by 52.04% to $9.7 million in 2023, then plummeted by 66.01% to $3.3 million in 2024, then decreased by 7.2% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $621973.0 for Q2 2025, and $1.7 million during Q1 2025.